No connection

Search Results

EVO vs SSII

EVO
Evotec SE
BEARISH
Price
$2.69
Market Cap
$963.7M
Sector
Healthcare
AI Confidence
60%
SSII
SS Innovations International, Inc.
BEARISH
Price
$4.89
Market Cap
$978.6M
Sector
Healthcare
AI Confidence
95%

Valuation

P/E Ratio
EVO
--
SSII
--
Forward P/E
EVO
-14.16
SSII
--
P/B Ratio
EVO
1.03
SSII
24.82
P/S Ratio
EVO
1.27
SSII
23.04
EV/EBITDA
EVO
55790.9
SSII
-135.09

Profitability

Gross Margin
EVO
10.82%
SSII
46.0%
Operating Margin
EVO
-26.6%
SSII
-5.06%
Profit Margin
EVO
-21.02%
SSII
-28.54%
ROE
EVO
-17.98%
SSII
-46.94%
ROA
EVO
-2.69%
SSII
-8.78%

Growth

Revenue Growth
EVO
-11.4%
SSII
79.1%
Earnings Growth
EVO
--
SSII
--

Financial Health

Debt/Equity
EVO
0.61
SSII
0.38
Current Ratio
EVO
2.12
SSII
1.86
Quick Ratio
EVO
1.15
SSII
0.82

Dividends

Dividend Yield
EVO
--
SSII
--
Payout Ratio
EVO
0.0%
SSII
0.0%

AI Verdict

EVO BEARISH

EVO shows bearish fundamentals based on deterministic rules. Financial strength is strong (F-Score 6/9). Concerns include weak profitability or high valuation.

Strengths
Company has established market presence
Risks
Low profit margin of -21.0%
Declining revenue (-11.4%)
Weak ROE of -18.0%
SSII BEARISH

SSII exhibits critical financial instability, highlighted by a Piotroski F-Score of 0/9, indicating failure across all fundamental health markers. While the company shows explosive revenue growth (79.1% YoY), this is decoupled from profitability, with a net profit margin of -28.54% and a severe valuation disconnect (P/S of 23.04). The stock is in a clear technical downtrend, having lost nearly 50% of its value in the last six months. Without a path to profitability or a correction in valuation, the current price is unsustainable.

Strengths
Exceptional YoY revenue growth of 79.10%
Strong Q/Q revenue acceleration of 158.45%
Healthy gross margin of 46.00%
Risks
Critical financial health failure (Piotroski F-Score 0/9)
Extreme overvaluation with a Price/Book of 24.82 and Price/Sales of 23.04
Negative profitability (ROE -46.94%, Profit Margin -28.54%)

Compare Another Pair

EVO vs SSII: Head-to-Head Comparison

This page compares Evotec SE (EVO) and SS Innovations International, Inc. (SSII) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile